Type 2 diabetes is reversible.
Accumulating clinical evidence demonstrates that type 2 diabetes can achieve remission through targeted nutritional interventions, metabolic surgery, and intensive weight-loss or pharmacological treatments.
The claim states that Type 2 diabetes is reversible (often referred to clinically as remission). All provided papers confirm that through lifestyle, nutritional interventions, bariatric surgery, or pharmacotherapy, patients can achieve sustained normoglycemia below the diagnostic threshold for diabetes. There is no contradictory evidence in the retrieved literature.
Bianchi C, Del Prato S, Rothberg AE, Nauck MA. Challenging the Consensus Statement: Is It Time to Recognise Pharmacological Remission of Type 2 Diabetes?. 2026. https://doi.org/10.1111/dom.70674
Discusses how intensive weight-management, bariatric surgery, and new pharmacotherapies can successfully achieve glucose and HbA1c levels below diagnostic thresholds for type 2 diabetes.
See more details
Chen J, Liu W, Bai Y, Jiao C. Contemporary perspectives on metabolic surgery for type 2 diabetes: surgical techniques, outcomes, and complications.. 2026. https://doi.org/10.3389/fendo.2026.1849157
Highlights the efficacy of metabolic surgery as an important therapeutic option for the management and potential resolution of type 2 diabetes.
Teshaev O, Murodov A, Jumaev N, Rakhmonova G, Lim I. Laparoscopic One Anastomosis Gastric Bypass (OAGB) for Type 2 Diabetes Mellitus: A 10-Year Single-Center Experience with 127 Patients.. 2026. https://doi.org/10.1007/s11695-026-08646-w
Demonstrates that laparoscopic bariatric-metabolic surgery achieves complete long-term diabetes remission in a high percentage of patients.
Pescari D, Mihuta S, Bena A, Pui R, Paul C, Stoian D. Nutrition-induced remission of type 2 diabetes: mechanisms, clinical evidence, and future directions-a mini review.. 2026. https://doi.org/10.3389/fcdhc.2026.1792614
Accumulated evidence shows that targeted nutritional interventions can successfully induce remission of type 2 diabetes.
Martínez-Montoro JI, Pinazo-Bandera JM, García-Serrano S, García-Almeida JM, Ocaña-Wilhelmi L, Moreno-Ruiz FJ, Soler-Humanes R, Ruiz-Campos N, Sancho-Marín R, García-Cortés M, Muñoz-Garach A, Fernández-García JC, García-Fuentes E, Tinahones FJ, Garrido-Sánchez L. Baseline Hepamet fibrosis score is associated with type 2 diabetes remission after bariatric surgery.. 2026. https://doi.org/10.1016/j.soard.2026.05.016
Evaluates predictors of type 2 diabetes remission following bariatric surgery, affirming that remission is an achievable clinical outcome.
Si Y, Tu Y, Wang Y, Zhang H, Han X, Liu W, Zhang P, Ma X, Yu H, Bao Y. Early Serum Clusterin Reduction is Associated with Weight Loss and Type 2 Diabetes Remission after Bariatric Surgery.. 2026. https://doi.org/10.1007/s11695-026-08732-z
Investigates biomarker dynamics associated with successful type 2 diabetes remission following metabolic and bariatric surgery.
The paper trail · every fact has a biography
Challenge the receipt
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
Terms · Privacy · How verdicts work · Dispute this receipt